Fattorini Paolo, Previderé Carlo, Carboni Ilaria, Marrubini Giorgio, Sorçaburu-Cigliero Solange, Grignani Pierangela, Bertoglio Barbara, Vatta Paolo, Ricci Ugo
Department of Medicine, Surgery and Health, University of Trieste, Trieste, Italy.
Department of Public Health, Experimental and Forensic Medicine, Section of Legal Medicine and Forensic Sciences, University of Pavia, Pavia, Italy.
Electrophoresis. 2017 Apr;38(8):1163-1174. doi: 10.1002/elps.201600290. Epub 2017 Feb 9.
Next generation sequencing (NGS) is the emerging technology in forensic genomics laboratories. It offers higher resolution to address most problems of human identification, greater efficiency and potential ability to interrogate very challenging forensic casework samples. In this study, a trial set of DNA samples was artificially degraded by progressive aqueous hydrolysis, and analyzed together with the corresponding unmodified DNA sample and control sample 2800 M, to test the performance and reliability of the ForenSeq DNA Signature Prep kit using the MiSeq Sequencer (Illumina). The results of replicate tests performed on the unmodified sample (1.0 ng) and on scalar dilutions (1.0, 0.5 and 0.1 ng) of the reference sample 2800 M showed the robustness and the reliability of the NGS approach even from sub-optimal amounts of high quality DNA. The degraded samples showed a very limited number of reads/sample, from 2.9-10.2 folds lower than the ones reported for the less concentrated 2800 M DNA dilution (0.1 ng). In addition, it was impossible to assign up to 78.2% of the genotypes in the degraded samples as the software identified the corresponding loci as "low coverage" (< 50x). Amplification artifacts such as allelic imbalances, allele drop outs and a single allele drop in were also scored in the degraded samples. However, the ForenSeq DNA Sequencing kit, on the Illumina MiSeq, was able to generate data which led to the correct typing of 5.1-44.8% and 10.9-58.7% of 58 of the STRs and 92 SNPs, respectively. In all trial samples, the SNP markers showed higher chances to be typed correctly compared to the STRs. This NGS approach showed very promising results in terms of ability to recover genetic information from heavily degraded DNA samples for which the conventional PCR/CE approach gave no results. The frequency of genetic mistyping was very low, reaching the value of 1.4% for only one of the degraded samples. However, these results suggest that further validation studies and a definition of interpretation criteria for NGS data are needed before implementation of this technique in forensic genetics.
下一代测序(NGS)是法医基因组学实验室中新兴的技术。它具有更高的分辨率,能够解决大多数人类身份识别问题,效率更高,并且有潜力检测极具挑战性的法医案件样本。在本研究中,通过渐进式水水解人工降解了一组DNA样本,并将其与相应的未修饰DNA样本以及对照样本2800 M一起进行分析,以使用MiSeq测序仪(Illumina)测试ForenSeq DNA Signature Prep试剂盒的性能和可靠性。对未修饰样本(1.0 ng)以及参考样本2800 M的系列稀释样本(1.0、0.5和0.1 ng)进行重复测试的结果表明,即使从质量欠佳的少量DNA中,NGS方法也具有稳健性和可靠性。降解后的样本每个样本的读数非常有限,比浓度较低的2800 M DNA稀释样本(0.1 ng)报告的读数低2.9至10.2倍。此外,由于软件将相应位点识别为“低覆盖”(<50x),因此在降解后的样本中高达78.2%的基因型无法分型。在降解后的样本中还发现了诸如等位基因失衡、等位基因缺失和单等位基因插入等扩增假象。然而,Illumina MiSeq上的ForenSeq DNA测序试剂盒能够生成数据,分别使58个STR中的5.1%至44.8%以及92个SNP中的10.9%至58.7%得以正确分型。在所有测试样本中,与STR相比,SNP标记正确分型的机会更高。这种NGS方法在从严重降解的DNA样本中恢复遗传信息方面显示出非常有前景的结果,而传统的PCR/CE方法对此类样本无法得出结果。基因分型错误的频率非常低,仅在一个降解样本中达到了1.4%的值。然而,这些结果表明,在法医遗传学中实施这项技术之前,需要进一步进行验证研究并确定NGS数据的解释标准。